Standard Biotools (LAB) Profit After Tax Growth (3y) (2013 - 2026)
Standard Biotools (LAB) Profit After Tax Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.45 Bn | 193.85 Bn | 7.27 Bn | -12.28% |
| 2 | Stryker | 127.62 Bn | 124.14 Bn | 4.50 Bn | 20.02% |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn | 1.93% |
| 4 | Boston Scientific | 73.41 Bn | 72.87 Bn | 3.85 Bn | 49.66% |
| 5 | Edwards Lifesciences | 51.89 Bn | 47.64 Bn | 1.35 Bn | -7.65% |
| 6 | Dexcom | 34.33 Bn | 32.38 Bn | 830.00 Mn | 29.05% |
| 7 | GE HealthCare Technologies | 33.87 Bn | 31.76 Bn | 2.18 Bn | 9.79% |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | 97.37% |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn | 15.46% |
| 10 | Standard Biotools | 252.86 Mn | -223.86 Mn | 10.54 Mn | -16.23% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -16.23% |
| Mar 31, 2026 | 112.12% |
| Dec 31, 2025 | 54.61% |
| Sep 30, 2025 | -2.50% |
| Jun 30, 2025 | 19.25% |
| Mar 31, 2025 | 32.59% |
| Sep 30, 2024 | 18.53% |
| Jun 30, 2024 | -8.33% |
| Mar 31, 2024 | -19.55% |
| Dec 31, 2023 | 57.48% |
| Sep 30, 2023 | -51.83% |
| Jun 30, 2023 | -9.40% |
| Mar 31, 2023 | -1.77% |
| Dec 31, 2022 | -18.01% |
| Sep 30, 2022 | -31.68% |
| Jun 30, 2022 | -66.55% |
| Mar 31, 2022 | -44.16% |
| Sep 30, 2021 | -50.03% |
| Jun 30, 2021 | -30.34% |
| Mar 31, 2021 | -12.42% |